Affordable Access

Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy.

Authors
  • Helton, E
  • Darragh, R
  • Francis, P
  • Fricker, F J
  • Jue, K
  • Koch, G
  • Mair, D
  • Pierpont, M E
  • Prochazka, J V
  • Linn, L S
  • Winter, S C
Type
Published Article
Journal
PEDIATRICS
Publisher
American Academy of Pediatrics
Publication Date
Jun 01, 2000
Volume
105
Issue
6
Pages
1260–1270
Identifiers
PMID: 10835067
Source
Medline
License
Unknown

Abstract

Results suggest that L-carnitine provides clinical benefit in treating pediatric cardiomyopathy. There is a need for further exploration of potential explanatory factors for the higher mortality observed in the population of patients treated with ACE inhibitors.

Report this publication

Statistics

Seen <100 times